Objectives: This study was conducted to examine whether the potentized homeopathic remedy Carcinosin 200, fed alone and in combination with Chelidonium 200, has differential protective effects against p-dimethylaminoazobenzene (p-DAB)-induced hepatocarcinogenesis in mice.
INTRODUCTION F
eeding of carcinogenic azo dyes such as p-dimethylaminoazobenzene (p-DAB) produces liver damage with neoplastic characteristics. 1 Dietary phenobarbital (PB) also has a positive carcinogenic effect only when fed conjointly with p-DAB in both mice and rats. 2, 3 In continuation of earlier works 4,5 the present paper reports the relative efficacy of a potentized homeopathic drug, Carcinosin 200 (Car 200), administered alone and in combination with Chelidonium 200 (Ch 200), in amelioration of p-DAB-induced hepatocarcinogenesis in mice. In homeopathy, various potencies of Chelidonium are routinely used against several forms of liver ailments, including liver cancer. Car 200 is also used as an intermittent medicine, particularly when malignancy is suspected. Carcinosin is believed to have the ability to modify favorably "symptoms in all cases in which a history of carcinoma can be elicited or Cytogenetics Laboratory, Department of Zoology, University of Kalyani, West Bengal, India.
Laboratory methodology
Slides for study of chromosomal aberrations (CA) were prepared from bone marrow cells by a conventional flamedrying technique. 4, 5, [9] [10] [11] [12] Five hundred (500) cells were examined in each series.
For micronucleus (MN) preparation, smeared bone marrow cells were stained with May-Grunwald stain. 12 Approximately 5000 cells, comprising both polychromatic erythrocytes (PCE) and normochromatic erythrocytes (NCE), were scored.
The mitotic index (MI ϭ dividing/nondividing cells) was assessed from the same slide that was scanned for MN. 13 For the sperm head anomaly (SHA) study, the technique of Wyrobek et al. 14 was adopted.
The activities of different biomarkers were assessed according to standard methodologies: for lipid peroxidase (LPO), 15 glutamate oxaloacetate (GOT) and glutamate pyruvate transaminase (GPT), 16 and acid phosphatase (ACP) and alkaline phosphatase (ALKP). 17 Histologic slides of liver at days 60 and 120 were prepared based on standard methods.
For electron microscopy of liver at days 60 and 120, the standard gold coating technique using critical point-drier (CPD-Biorad, Microscience Division, Warford, England), sputter-coater (model 198, Agar Sputter Coater, Stansted, United Kingdom) was adopted in case of scanning electron microscopy (LEO, 435VP, United Kingdom). For transmission electron microscopy (TEM; CM-10, Philips Electron BISWAS ET AL. 840 
RESULTS
The incidence of tumor nodules in different groups of mice is shown in Table 1 . In general, both number of tumor nodules and their size appeared to be slightly reduced; quite a few mice even showed liver without tumor nodules in both the p-DABϩPBϩCar 200-fed and p-DABϩPBϩCh 200-fed series, more appreciably in the latter. However there was no further reduction in the number of mice showing tumor nodules in the conjointly fed (p-DABϩPBϩCh 200ϩ Car 200) series. On the other hand all mice in the pDABϩPBϩAlc 200-fed series showed tumor nodules as did those in the p-DABϩPB-fed group. The data on different cytogenetic endpoints such as CA, MN, MI, and SHA are summarized in histograms in Figures 1A-1D , and a few representative photographs of typical ones are provided in Figures 2A-2I) The extent of genotoxicity (CA) was generally suppressed or reduced quantitatively in both the pDABϩPBϩCh 200-fed and p-DABϩPBϩCar 200-fed mice compared to p-DABϩPB-fed mice at some specific fixation intervals, but the suppression or reduction was greater (p Ͻ 0.01 to 0.001) in scale in the conjointly fed mice at all fixation intervals (Tables 2 and 3 ). On the other hand the genotoxicity and cytotoxicity appeared to be appreciably enhanced in the p-DABϩPBϩAlc-fed mice (Fig.  1A ) compared to both normal and DϩPB-fed mice (p Ͻ 0.01 to 0.001).
Similarly the combined drug-fed series showed fewer of micronuclei than either drug-fed series at all fixation inter- 
HOMEOPATHIC DRUGS AMELIORATE LIVER CANCER IN MICE 841

C D B A
vals (p Ͻ 0.001), although feeding of drug also brought down the incidence of MN considerably at most fixation intervals (Fig. 1B) .
The MI in p-DABϩPB or p-DABϩPBϩ Alc 200 steadily increased with time, as compared to values in normal controls (Fig. 1C) . However the MI actually decreased in mice fed either Car 200 or Ch 200. The MI was also appreciably reduced in the combined drug-fed series but not to the extent as in the Ch 200-fed mice.
Similarly there was a clear suppression or reduction in the frequency of SHA in mice fed either drug alone or both drugs conjointly, compared to mice given either p-DABϩPB or pDABϩPBϩAlc 200, at most fixation intervals (Fig. 1D) .
Data on activities of various toxicity marker enzymes are presented in summarized form in Tables 4-8 tissues and at all fixation intervals compared to values in normal controls (p Ͻ 0.001). The p-DABϩPBϩCh 200-fed mice generally showed a trend of decrease, sometimes marginally and sometimes quite appreciably in certain tissues and at certain fixation intervals. However a more pronounced reduction in GOT activity was found in some tissue of conjointly drug-fed mice at some specific fixation intervals (p Ͻ 0.05 to p Ͻ 0.001; Table 5 ).
There was an increase in GPT activity in mice fed p-DABϩPB and p-DABϩPBϩAlc. In the p-DABϩPBϩCar 200-fed series the GPT activity appeared to be somewhat erratic, slightly decreased or even sometimes slightly increased in some tissues, at some fixation intervals (Table 6 ). However in the p-DABϩPBϩCh 200-fed mice the decrease in GPT activity was appreciable at most fixation intervals, and was the case in the combined drug-fed series.
Compared to controls, there was an increase in the ACP activity in the mice given p-DABϩPB and p-DABϩPBϩ Alc (p Ͻ 0.001), but the activity substantially decreased in those fed p-DABϩPBϩCh-200 and combined drugs (p Ͻ 0.05 to p Ͻ 0.001), although not consistently at every fixation interval (Table 7) .
Similarly, there was an increase in the ALKP activity in mice given p-DABϩPB and p-DABϩPBϩAlc (p Ͻ 0.001), while the activity was substantially decreased in both the p-DABϩPBϩCh 200-fed and combined drug-fed series (Table 8 ), compared to the p-DABϩPB and the p-DABϩ PBϩAlc-fed series.
Overall the mice that were fed either drug, alone or in combination, showed effective modulations of their enzyme levels indicative of the protective nature of the drugs, which were slightly more pronounced when the drugs were conjointly given.
Under optical microscopy, the liver sections of p-DABϩPB-fed mice at day 120 (Fig. 3 ) revealed more drastic tissue damage and necrosis than at day 60 compared to the liver sections of normal controls. A few notable areas of damage caused by the carcinogens were as follows: more than one nucleus was present in some hepatocytes, excessive fibrosis in the hepatic parenchyma was noticed; and cytoplasmic boundaries of the hepatic cells were barely recognizable and also more infiltration of leukocytes among the parenchyma was evident. In the p-DABϩPBϩCh 200-fed series (Fig. 4) reduced (e.g., the binucleate or multinucleate cells were much fewer, and more cells had distinct boundaries. In the p-DABϩPBϩCar 200-fed series (Fig. 5) , although the number of unhealthy Kupffer cells was not drastically reduced, infiltration of the cells in the parenchyma was not evident. However in the combined drug-fed series (Fig. 6) , relatively less loss of cytoplasm was evident; the nuclei of the cells were found to be intact; and vacuolated cells were fewer.
Analysis with scanning electron microscopy (SEM) revealed that fibrosis was evident; there was tissue necrosis causing the appearance of holes; and a blood-liver barrier was not present in the p-DABϩPB-fed series (Fig. 7) . Furthermore, red blood cells (RBCs) were found among parenchymal tissue, which was suggestive of breakdown of the bloodliver barrier. In the p-DABϩPBϩCh 200-fed series (Fig. 8) , most cells had intact nuclei and some of the cells were arranged in chords; but still the blood liver barrier did not appear to be intact as many RBCs were located outside the cells.
In the p-DABϩPBϩCar 200-fed series (Fig. 9 ) tissue damage was evident but few of the Kuffer cells were present and the blood-liver barrier was broken. In the combined drug-fed series (Fig. 10) , edematous swelling was not evident and tissue necrosis was less persistent; a few cells, apparently newly generated, were found to be arranged in chords.
Examination with TEM also revealed damage to intercellular organelles in the p-DABϩPB-fed series at both days 60 and 120 (Fig. 11) . A few notable changes were as follows: the endoplasmic reticulum was broken and numerous mitochondria were present in each cell; Kupffer cells were activated; and lipid droplets were numerous. The activation of Kupffer cells might suggest increased secretion of lymphokines. In p-DABϩPBϩCh 200-fed mice (Fig. 12) , lipid droplets were few and the endoplasmic reticulum was less broken. The number of Kupffer cells was also fewer. In pDABϩPBϩCar 200-fed mice (Fig. 13) ; however, the recovery or protection was not as convincing and striking as either in p-DABϩPBϩCh 200-fed or combined drug-fed mice (Fig. 14) . In the latter series damage to hepatocytes was not fully recovered, but the numbers of mitochondria, lipid droplets, and broken ERs were fewer.
DISCUSSION
The efficacy of Car 200, given alone or in combination with Ch 200, has not previously been tested. Furthermore, evidence of modulations induced by any potentized homeopathic drug at the ultrastructural level seems not to have been documented earlier. The results of this study demonstrate that Car 200, when administered orally to mice chronically fed p-DABϩPB, apparently showed some amount of antitumoric, anticlastogenic, and anticytotoxic effects; but the efficacy was apparently less than that of the Ch 200-fed group. However the conjoint treatment of Ch 200 and Car 200, which is often adopted by homeopathic practitioners in case of a suspected liver cancer, showed a more pronounced potential of antagonism and protective action against the carcinogens.
Different aspects of how p-DAB and PB induce hepatocarcinogenesis through their degradation and action of their metabolic products have already been extensively studied. 3, [18] [19] [20] [21] [22] Covalent binding of the metabolites of p-DAB (such as, monoaminoazobenzene and aminoazobenzene) with DNA is believed to be a major carcinogeneic factor. 22 Thus the potentized homeopathic drugs appear to have the ability to block or interfere with the carcinogenic action of carcinogens, either by directly antagonizing their effects or by reversing their ill effects to a considerable extent.
Although both Ch 200 and Car 200 were made in same alcoholic vehicle as Alc 200, only the former showed some protective action against the formation of the liver tumor nodules (few of which at day 60 may actually represent preneoplastic lesions, although others were tumors) whereas the Alc 200 did not.
Crude extracts of the Chelidonium majus plant have been reported to have several isoquinoline alkaloids, and both crude extracts and purified compounds derived from C. majus have been reported to exhibit antiviral, anti-inflammatory, antitumoric, and antimicrobial properties, as well as inhibitory effects on growth of keratinocytes in human beings 23 and on lipoxygenase activity in mice. 24 In addition a stimulatory effect has been reported on bile acid-independent flow in the isolated perfused rat liver. However it is difficult to explain how the ultra-high dilutions of Chelidonium could successfully combat such strong carcinogens by bringing about so many positive changes. Because of their minimal side-effects, these homeopathic remedies may serve as potential candidates for future trials in complementary and alternative medicine (CAM) examine their suitability for treatment and management of human liver cancer.
BISWAS ET
Because the various changes noted in this study can only be brought about ultimately by the activity of certain genes, it may be hypothetized 7, 25 that these potentized drugs could somehow manage to correct the expression of certain relevant genes (presumably by eliciting suitable signals to trigger "on" or "off " specific genes), the regulation of which had faltered because of the carcinogens, and for which they had started functioning abnormally.
CONCLUSIONS
As most conventional chemopreventive therapies used at present have toxic side-effects that preclude their effective use in many cases, alternative agents with minimal side-effects on normal cells that effectively destroy or inhibit cancer cells need to be identified. Therefore CAM is gradually becoming popular, particularly in oncology, which often requires a number of therapies, from homeopathy to acupuncture, 26, 27 especially as supporting palliative measures. [28] [29] [30] [31] [32] Recently a homeopathic drug, Ruta 6, has been reported to induce cell death in brain cancer cells, 35 as revealed by both in vivo and in vitro studies, indicating the need for other similar studies.
